Advanced Energy Industries Inc Q4 FY2021 Earnings Call

Greetings. Welcome to Advanced Energy's Fourth Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. Please note, this conference is being recorded. I will now turn the conference over to your host Edwin Mok, Vice President of Strategic Marketing and Investor Relations. You may begin.

Thank you, operator. Good afternoon, everyone. Welcome to Advanced Energy’s fourth quarter 2021 earnings conference call. With me today are Steve Kelley, our President and CEO; and Paul Oldham, our Executive Vice President and CFO. If you have not seen our earnings press release, you can find it on our website at ir.advancedenergy.com. There you will also find the Q4 earnings presentation. Before I begin, I'd like to mention that we will participate at several investor conferences in the coming months. Let me remind you that today's conference call contains forward-looking statements that are subject to risks and uncertainties that could cause the actual results to differ materially and are not guarantees of future performance. Information concerning these risks can be found in our SEC filings. All forward-looking statements are based on management's estimates as of today, February 9, 2022, and the company assumes no obligations to update them. Medium- and long-term targets presented today should not be interpreted as guidance. On today's call, our financial results will be presented on a non-GAAP financial basis unless otherwise specified. Excluded from non-GAAP results are stock compensation, amortization, acquisition-related costs, restructuring expenses, and unrealized foreign exchange gains or losses. A detailed reconciliation between GAAP and non-GAAP measures can be found in today's press release. With that, let me pass the call to our President and CEO, Steve Kelley. Steve?

Thank you, Edwin. Good afternoon, everyone, and thanks for joining the call. We finished the year strong, with revenue of nearly $400 million in the fourth quarter, a new record for Advanced Energy. For the full year, we achieved revenue of $1.46 billion, also a record performance. Demand for our products is very strong, and we carried a more than $900 million backlog into 2022. We're also pleased with customer acceptance of our new products and technologies across a wide variety of applications. During 2021, we fine-tuned our growth strategy, clarified our product roadmaps, added senior management talent, and increased the onboarding tempo of the company. We successfully integrated two acquisitions, Versatile Power and Tegam, which brought valuable medical, sensing, and calibration expertise to Advanced Energy. Our short-term financial performance remains constrained by IC shortages. However, it's important to note that our engineering and marketing teams remained squarely focused on developing market-leading technologies and products, which will drive the long-term profitable growth of Advanced Energy. Our sales teams are focused on taking those new technologies and products to customers throughout the world. At our core, we are all about precision power technology leadership, and delivering that technology in a way which adds value for our customers. Now I will provide more color on our fourth-quarter and full-year performance. Fourth-quarter revenue and earnings per share surpassed the high end of our guidance. We secured additional critical ICs, which enabled us to ship more product than originally anticipated. This ability to quickly turn incremental parts into product revenue stems from a decision we made last year to keep our factories fully staffed, even though component shortages were constraining output. This full staffing approach gives us the surge capacity we need to take advantage of unexpected or lumpy delivery of critical ICs, and it paid off for us in the fourth quarter. Moving to the supply chain challenges, the semiconductor supply chain remains dynamic. Most of the ICs we buy are built on mature process nodes, and that is where most of the industry-wide capacity constraints are. Many of our suppliers are working diligently to expand capacity, and most of that incremental capacity is scheduled to come online later this year or in early 2023. In addition, we're working closely with our customers to qualify alternative ICs with better availability. In summary, we expect that IC shortages will continue to be an issue for much of this year, although we do expect improvement in the second half as new capacity comes online and our qualification and redesign efforts bear fruit. We continue to pay abnormally high prices to secure critical ICs in short supply. We also continue to experience unexpected supply from certain IC suppliers. Given these factors, we are taking a prudent approach to our near-term outlook. Now I’d like to provide color on each of our target markets. Our fourth-quarter shipments into the semiconductor market grew sequentially and year-over-year. For the full year, we achieved record revenue despite persistent supply issues. Over the past two years, our semiconductor revenue grew by 76%. In the first quarter of 2022, we expect to grow semiconductor revenue sequentially and year-over-year. At the Semicon West tradeshow in December, we launched three new products for the edge and deposition markets, which featured advanced control capabilities. Also in the fourth quarter, we won multiple new designs with our high voltage, critical sensing, and embedded power products. In the industrial medical market, our fourth-quarter revenue was up sequentially and year-over-year on improved component availability. In fact, fourth-quarter as well as full-year revenue in this market hit an all-time high. We expect robust demand in the industrial medical market in 2022 and carried a substantial backlog into the first quarter. During the fourth quarter, we launched three new industrial and medical products. In addition, we secured design wins in medical, test and measurement, horticulture, and solar cell manufacturing applications. In the data center computing, telecom, and networking markets, fourth-quarter revenues were well ahead of expectations due to improved component availability. During the quarter, we launched our next generation 48-volt power shelf, which features 97% efficiency in industry-leading power density. Our telecom revenue grew in the fourth quarter, largely due to increased demand for 5G infrastructure equipment. Now I'd like to touch on our strategy and some of the changes we've made in the past year to accelerate our growth initiatives. Our overall strategy is to drive profitable revenue growth by delivering best-in-class precision power solutions to customers in our target markets. Our customers rely on Advanced Energy’s innovation and technical talent to solve their most challenging power delivery issues. The solutions we developed are typically proprietary and are the foundation of our long-term growth strategy. During 2021, we reorganized our product development and marketing teams to improve the speed and efficiency of our new technology and product development processes. We put a new leadership team in place, blending longtime Advanced Energy leaders with new leaders from outside the company. The team works well together, and our shared priorities are clear. In addition, we have allocated more engineering resources to the semiconductor, industrial, and medical markets. We expect to increase our new product output and win more designs in these markets. Finally, we have taken major steps to strengthen our operations in the supply chain organization. We believe that we are well prepared to quickly turn improved component availability into product revenue. In closing, demand for our industry-leading precision power solutions remains extremely strong. We expect that a gradually improving supply chain environment coupled with our shortage mitigation actions will drive revenue growth in the second half of the year. As a company, we remain focused on accelerating the execution of our long-term strategy to bring best-in-class, precision power solutions to customers in our target markets. Paul will now review our financial results and provide detailed guidance.

Thank you, Steve, and good afternoon everyone. In the fourth quarter, we delivered revenue and earnings per share above the high-end of our guidance ranges. Good execution by our team allowed us to secure additional parts, increase factory output, and begin to recover material cost premiums we've incurred. Demand also increased with our backlog growing another 20% to $928 million. Our strong Q4 performance demonstrates that as we receive parts, we're able to quickly convert that supply to revenue. Looking forward, however, industry-wide supply constraints persist, and the environment is very dynamic. As a result, we continue to plan prudently in the near-term but see significant pent-up earnings potential as the supply environment improves. Now let me go over our financial results. Fourth-quarter revenue was a record $397 million, up 15% sequentially and 7% year-over-year. Sales in the semiconductor were $179 million, growing 3.4% sequentially and 8% from last year. Demand remains strong, driven by robust fab investments, and we expect semiconductor revenue to grow sequentially again in the first quarter. Revenue from our industrial and medical markets grew 22% sequentially and 5% from a year ago to a record $99 million. We secured more parts than anticipated, allowing us to achieve the strong performance. Customer demand was broad-based, and our backlog in this market increased again this quarter. Data center computing revenue rebounded to $80 million, up 29% sequentially, and 23% year-over-year. Telecom and networking revenue was $39 million, up 31% sequentially, driven by strong telecom shipments to 5G infrastructure, but down 16% year-over-year as a result of our portfolio optimization actions. Non-GAAP gross margin for the quarter declined slightly to 35.5%, mostly related to increased material costs and unfavorable mix. In addition, during the quarter, we recovered from our customers a portion of the premiums we have incurred for purchasing high-cost materials. These premium recoveries benefited revenue, but negatively impacted gross margin percentage by approximately 150 basis points. We expect increased material costs and premium recoveries to continue to impact our gross margin percentage in the near term, but to improve later in the year. Non-GAAP operating expenses were $86.1 million, up $2.5 million from last quarter. The sequential increase was due to investments in critical programs and higher SG&A expense. Operating margin for the quarter was 13.8%. Other expense was $2.5 million, including $1.2 million of interest expense and $700,000 of foreign exchange losses. We expect other expense to be in the $2 million range going forward. Our non-GAAP tax expense was approximately $850,000. The lower-than-expected tax cost was largely due to a year-end discrete benefit. Excluding this item, the adjusted tax rate would have been approximately 12.5% on a favorable mix of foreign earnings and increased R&D tax credits. Looking forward, we continue to expect our GAAP and non-GAAP tax rate to be in the 15% range. Earnings for the quarter were $1.36 per share, compared to $0.89 last quarter. Excluding the discrete tax benefit, earnings would have been $1.21 per share. Turning now to our full-year 2021 financial results, we achieved record revenue of $1.46 billion, up 3% from 2020 despite the COVID-related impact on our operations and the industry-wide supply constraints. Semiconductor revenue grew 16%, and industrial and medical revenue grew 9%, both to record levels. Sales into the data center computing and telecom networking markets declined due to supply constraints of critical ICs and our portfolio optimization actions. Increased material costs related to supply constraints was the primary factor impacting our gross and operating margins. As a result, 2021 non-GAAP earnings declined year-over-year to $4.78 per share. Turning now to the balance sheet, we ended the fourth quarter with total cash of $547 million and net cash of $154 million. Cash flow from continuing operations for the quarter was approximately $35 million, and CapEx was $9.2 million. We made debt principal payments of $5 million and paid $3.8 million in dividends. In addition, we repurchased $21.5 million of common stock at $85.12 per share as part of our opportunistic share repurchase program. Days of net working capital in Q4 decreased to 118 days on higher revenues. Inventory decreased slightly on a dollar basis, and turns improved to 3.1x. We expect to see some upward pressure on inventory in the near term based on demand. But believe this investment allows us to respond quickly to customer demand as critical parts shortages abate and represents upside to operating cash flow over time. Days payable fell to 68 days, and DSO decreased to 54 days. For the full year of 2021, we generated $141 million of cash flow from continuing operations despite our investment in raw materials inventory while we await critical parts. In addition, we used $78.1 million to repurchase over 900,000 shares of our common stock during the year. Now, let me turn to guidance. We expect the supply environment to remain dynamic, with continued risk on timing of critical component deliveries. Our order book increased even after the strong Q4. We expect revenue will continue to be paced by supply. As a result, our Q1 outlook remains largely unchanged from the view we provided last quarter. We expect Q1 revenue to be approximately $360 million plus or minus $20 million. Our Q1 guidance assumes semiconductor revenue will grow sequentially, while revenues in the other markets will decline limited by availability of parts. We expect Q1 gross margin to improve slightly on lower volume. Overall, material costs remain elevated, but we expect more favorable product mix and relatively lower material premiums and related recoveries. We expect operating expenses to be up slightly. As a result, we expect Q1 non-GAAP earnings per share to be $0.94, plus or minus $0.25, based on a share count of approximately 37.7 million shares. Before I open it up for questions, let me make some comments beyond the current quarter. We entered 2022 with strong demand and record backlog, with a greater than 70% mix of proprietary products that can largely be shipped as soon as we can secure parts. Based on this last quarter, we provided an outlook that called for revenue of over $400 million per quarter as supply improves towards the end of 2022. While we do not expect meaningful improvement in the first half, we remain confident in our ability to achieve these revenue levels or higher on a sustained basis as parts become available. In addition, as premium costs normalize, we believe we can deliver greater than $6 per share of annualized earnings exiting this year, with additional pent-up earnings potential in 2023. With that, let's take your questions.

And at this time, we will be conducting a question-and-answer session. Our first question comes from the line of Quinn Bolton with Needham & Company.

Hey, guys, nice execution in the fourth quarter. I guess looking at the strength and the components you're able to secure in Q4. I have to assume your guidance implies that you think your components received in the March quarter are probably down about 10% or sort of in line with the revenue guide. Is that the way you're looking at component availability in the first quarter?

Yes, Quinn, I will make a comment. This is Steve Kelley. So in Q1, we're looking at our current line of sight for parts. So what we can see in front of us over the next seven or eight weeks to the end of the quarter. The second thing we're trying to do with our guidance in Q1 is to make sure we've got a relatively high degree of confidence in our midpoint guide. I think there's always a chance we'll do better. But it's very hard to forecast these critical IC deliveries. Last quarter, we were surprised on the upside with the unexpected, lumpy delivery of ICs. We hope that happens again, but we can't forecast it.

So it sounds like that lumpiness that allows you to beat the fourth quarter is truly lumpy. And you haven't seen that activity continuing in the month of January and February to-date, at the same level you saw it in Q4?

It's hard to characterize. I think we have received what we expected to receive so far this quarter. Typically, most of the action takes place in the second half of the quarter, as our suppliers reallocate their product. That's a pretty dynamic process, so it's hard to forecast.

Understood. And then, for Paul, I was hoping you could give us a little bit more color on the premium recovery that you talked about. Premium recovery to me sounds like you're able to pass along some higher input costs, or you're able to charge a higher price for your products. But I think you said that premium recovery actually was a drag on gross margins. But I think you said 150 basis points. Maybe I misheard, but can you just spend a minute and explain what's going on there with a premium recovery?

That's right. It's a good question, Quinn. So as we've noted, we're paying in some cases significant premiums to get parts, sometimes just on the open market. Our customers support us getting those parts because it's sometimes the only path to getting product to them. And so we've been able to increasingly pass along that cost to them. However, when we pass that cost along to them, essentially, we're receiving revenue that covers the cost of those parts. So it's essentially revenue at 100% cost. And so it's helped our revenue in the quarter, but it increased our costs sort of at an equivalent level. Now, the good news is we recovered that cost; otherwise, we would have just had the cost. But that's why you see a negative impact to the gross margin percent because you have more revenue going through not in our traditional margins, but more at a cost recovery level.

And our next question comes from the line of Steve Barger with KeyBanc Capital Markets.

Hi, how much of the backlog is currently work in progress and just waiting on ICs? I'm just trying to get a sense for how that will affect working capital and cash flow as the year progresses?

Yes. I think the way to think about it, Steve, is when we look at what we would consider delinquent backlog, product the customer was already wanted, and that they want in the coming quarter, we would characterize more than 50%, maybe 60% or more is sort of shippable in the next quarter, just awaiting those critical parts. Now we're not going to be able to ship all that because there's no way we'll get those parts in time. But it tells you that it's a very current backlog. Now, we've seen increases in the backlog that go out one or two or three quarters as well. But the vast majority is shippable as soon as we can build it. I think Q4 is an example of where we were able to get some parts, and we're able to turn around those very quickly. And you saw a little burst in revenue as a result of that. So it all comes down to how quickly and when we receive these critical parts. But certainly as we look across the year and supply environment improves, it gives us confidence that we could operate at a much higher level in revenue and a much higher level of earnings as parts become available.

Yes. I guess to that point, I know you started requalifying new suppliers last year. You mentioned that those efforts are underway. But can you be a little more specific about potential timing of that process? And realistically, when you could see some benefit that could help you start to draw down that backlog?

Yes, I think the team has done a good job working with our customers to quickly qualify alternate parts and also, in some cases, do redesigns of existing boards to accommodate new parts. I think that has progressed very well. We expect the major impact to occur in the second half of this year. So we're seeing some positive effect in the first half, but most of it will take place in the second half of 2022.

Our next question comes from the line of Krish Sankar with Cowen and Company.

I had a couple of them too. First one, Steve, when I look at your semi revenues last year, 15%. I understand what constraints kind of really limited the growth. But if we look at your U.S. peer, who has also experienced similar constraints, is there any business that grew to almost twice your growth rates? I'm kind of curious what's going on with your semi? I mean, I have a follow-up.

Yes. Let me answer your question in two parts, Krish. I guess the first is the strategic share, right? And that's really determined by wins or losses in our core market, which is conductor edge. What we're seeing so far is that we're winning all the major opportunities there in conductor edge, and I think we're doing a pretty good job defending our strongest products. In addition, we have some new technologies that will allow us to grow share in the coming years and some new areas like RPS and dielectric. As I think, when you're looking strategically at market share, you need to take a look at your design ends, and then the time lag between design ends and production. But I feel pretty good about where we're at. Your question is more on the technical market share. Our starting point would be 2020. If we look at the two-year period, we've grown our semiconductor revenues by 76%, which is ahead of WFE. We outgrew in 2020 because our customers ordered early for the burst in 2021. We underperformed quite frankly in 2021 because of the parts issues that we ran into. Our objective is to get better in 2022 from a shipment standpoint in semiconductor. We intend to keep up with demand and also start rebuilding the hub inventories, because last year, our customers coped with our shipping problems by eating into their hub inventory and now we have to help them rebuild the inventory.

Got it. Thanks for that, Steve. And then a follow-up for Paul. And I'm just trying to look at the linearity of the numbers in the income statement. It looks like as the year progresses, your revenue should improve. If and when supply constraints ease and create like a 400 million run rate in quarterly revenues. And at the same token, the second-half gross margin should be better. A) Is that right? And then how do we think about OpEx? I tried to do the math, it seems like your OpEx is going to outgrow revenue growth this year 2021, right?

Yes, so a couple of things, Krish. The first is that you're right; we would expect results to improve over the course of the year. But it's important to think about the seasonality of that. We do think that the parts environment that we're in continues to be challenging. We expect that to continue not only to Q1 but into Q2 as well. Many of the actions that we have taken internally around part redesigns and even when we look at when more parts are going to become available, we believe that's more in the second half. So we would expect to see Q2 very similar to Q1, when we look at our outlook, just based on parts availability. Now, as those parts become available, as I mentioned earlier, I think we have upside to our revenue levels, which is why we've said that we expect to be able to exit the year at this $400 million rate or better. And the second thing is, as this supply chain situation normalizes and we don't have these, I'll say premium costs where we're paying for higher-priced parts on the open market, that's going to also have a significant improvement in gross margin, which allows us to get to an exit rate of over $6 a share annualized. So we do think that the key to this is just parts availability and that there's a lot of pent-up earnings in the company. The question is timing. Our best view of that timing is its second half, and exiting the year we should be performing at a much higher financial level.

Awesome. Terrific. Thanks for the color, Paul.

Our next question comes from the line of Mehdi Hosseini with SIG.

I joined the call late, so I apologize for repeating a question that has already been asked? Steve, I understand you may not want to comment on WFE. But some of your OEM customers have talked about 100 billion WFE this year, which is very substantial and hitting new highs. I'm just wondering, when you talk about component availability in the second half of the year? Should we assume that the way you're catching up with components and your shipment will accelerate into the second half? Would that be enough to support 100 billion WFE? And I have a follow-up.

Yes, Mehdi, that's a tough one. I think all indications from our customers are that 2022 and 2023 are going to be extremely strong. If you take a look at the underlying fundamentals, they are very positive, right? The trend towards 5G and artificial intelligence and industry 4.0, etc., are driving some pretty strong secular growth. I think the other trend that's important is many of the customers for chips are moving to adjusting case inventory posture, which means not only just buying what they need but also putting some insurance in place from a part standpoint. Finally, you've got the number of regions in the world trying to become self-sufficient in chips, which is driving even more equipment. So I think WFE is likely to grow quite well in 2022. Probably as an industry, we're going to be limited by parts, right? It hits us, it hits the rest of the critical subsystem suppliers, and hits our customers. We have to work together and make sure we get the parts we need to expand capacity in this very important ecosystem.

Sure, thank you. I just have a follow-up to that. The same OEMs have a consistent message that this is secular, and we are in a new paradigm shift, especially with localization, and WFE will continue to grow probably through 2025. Given their premises, what are the opportunities? What would it take for your OEM customer to become a partner with you and co-invest for supply chain for hub inventory management, so that once we come out of later this year, both parties are able to help each other and benefit from the secular trends?

Yes, Mehdi, I think really, it's not a question of money. We have the ability to expand our own capacity relatively quickly and at relatively low cost. The issue is getting the parts. So it's really our suppliers expanding their capacity and their ability specifically to build more product at older nodes. Almost everything we buy is 28 nanometers to 180 nanometer type products. So it's mature and it's been in contention this year, as the automotive industry came back to life and basically economies boomed around the world. So we're all fighting for that limited capacity. We're seeing the IDM make more investments in older nodes. We're also seeing the same things happening at the foundries. It takes some time to bring the capacity down, but it'll come. Over the next six to 12 months, we're going to see things settle down.

Our next question comes from the line of Tom Diffely with D.A. Davidson.

Steve, just following up on Mehdi's question. Do you think the OEMs will require you to hold a larger inventory going forward, or maybe have a larger hub inventory going forward?

Oh yes. I think two things will happen. One is, our OEM customers will rebuild their safety stocks. They may adjust those stocks a little bit depending on their risk tolerance. So that's probably going to be good news for us. The second is, we're examining our own supply chain. Where we can, we're going to build inventory where we identify weak links. We're also going to upgrade. In many cases, buying parts that are built in factories that may not have long-term expansion plans. At that point, it's up to our engineers to upgrade the technology, so that we're using parts that will be available and plentiful for many years to come. So those two actions will be proceeding this year.

Okay, great. Maybe just a little bit more color on the supply dynamics. When you get a slug product like you did in the fourth quarter, is that driven by your core suppliers just giving you more allocation? Are they actually producing more? Are you finding new suppliers or possibly even finding them new markets?

In this case, it was a couple of recourse suppliers who allocated more to us. There's a lot going on behind the curtain, quite frankly that we don't see. But we're certainly happy to see the parts show up on our dock, and we put them into products and shipped those products very quickly. I think that's the power of our model; we've maintained full staffing and full capacity throughout the company, despite the part shortage. So when we do get those upsides, we can turn them into revenue very quickly.

Okay, great. And then, Paul, you talked a bit about the telecom business being down a bit on a year-over-year basis. How much of that was your portfolio optimization versus supply issues?

It's a mix of both. I believe it's reasonable to say it's about half and half. Last year in the fourth quarter, we experienced a strong performance in telecom and networking as customers were purchasing in advance of product price changes or phase-outs. As you may recall, in Q1 we adjusted to a lower number in the low 30s, which we identified as a new baseline. We've seen solid demand from that new baseline this year, but we've been unable to meet it due to parts shortages. In the fourth quarter, we received some parts, which allowed us to increase that number. So, it's a combination of both factors at play.

Okay, then, last question here. When you look at the optimization, are you done with that process? Or is there still more to do?

I think in telecom and networking, that's largely done. We tried to do this optimization effort, which is kind of an ongoing effort to kind of feather it in and blend it in. We didn't want to put any of our customers in a difficult situation. We're trying to do this in a bit of an elegant way. I just think in that particular market, it ended up being more visible around that calendar year-end. We're constantly looking at how to improve our portfolio, how to raise prices in areas where we have lower margins, and how to focus our engineering resources on areas that offer more differentiation. So I'd say it's more of an ongoing process, but it shouldn't be as visible overall as what we saw in telecom and networking last year.

And our next question comes from the line of Pavel Molchanov with Raymond James.

Mine are actually not about the supply chain, believe it or not. We're in the third year of COVID, and I wanted to ask what is the kind of near-term outlook for medical, or the medical component of your industrial and medical segments? Are you seeing any deceleration in healthcare application demand as the pandemic subsides, so to speak?

Yes. We're seeing indications of increased activity both on the revenue side and the design side. We're quite happy with the level of design wins that we're earning in that market. We're seeing medical revenue pick up, so I think 2022 would be a good year for the medical market and a good year for us.

Okay, interesting. That's a little counterintuitive. And then on the dividend, so I guess this quarter marks the one-year mark of your institution of the dividend. Given that yield on the stock, obviously, is pretty moderate 50 basis points. Any perspective on moving to a progressive dividend policy, or just any thoughts on that front?

Yes, it's a good question. Broadly speaking, when we put out our model, we said we would assign a portion of our cash flow to the dividend. Generally speaking, we said we'd review that periodically over time, which the Board does. At this point, we haven't made a decision to increase the dividend. Certainly, the company can perform at a higher level, and we want to make sure we have cash in the right places. We've not increased the dividend at this point. Certainly, that's something that we could continue to look at over time. But at this point, given the parts constraints, we've not increased the dividend.

Next question comes from the line of Paretosh Misra with Berenberg.

So besides some of the supply chain issues that are impacting your margins at the moment, are there actions that are under your control that can potentially help as well, for example, manufacturing footprint optimization and other cost-cutting measures?

I'll make a comment then turn it over to Paul. I think when you look at our costs, the great majority of the costs are in the building materials. There's not that much we could do, trying to optimize the manufacturing footprint that offsets the parts costs. In fact, we don't want to do that because we see many opportunities to expand our manufacturing once the parts shortages are rectified. We're probably going to build more capacity; this is a fact we are building boxes and shipping those boxes after we test them. It's not a wafer fab, right? It's not a clean room; it's relatively inexpensive capacity.

Yes. I'll just add a couple of comments. Steve's exactly right. I would add, however, that this environment where you're struggling with full kits is quite disruptive. It consumes a lot of time on the supply chain side, and it's quite disruptive in the factory. We do believe that as the environment improves, there will be opportunities for us to improve the efficiency of our operations, and that's something that we continue to focus on. We are carrying some additional cost from a factory that we're exiting in China so that we can have some of that capacity in place. It’s not very efficient right now, but it does add to our ability to output more. So I think over time, there will certainly be opportunities for us to improve efficiency. Regarding cost, a lot of these increased costs right now we think are transitory. They are in the form of these material premiums that we're paying. Unfortunately, we're starting to be able to pass those on. It doesn't help the gross margin percent, but over time, those will abate and that should improve our margin significantly. There's also some structural inflation in material cost. We think by and large, we'll be able to recover that largely through price increases over time. We do think there’s a clear path to get back to our model of gross margins of 40% or better. We believe we can be very close to that as an exit rate this year, assuming we see some of the abatement we've talked about in the supply environment.

Got it. Thanks for that. And then this new next generation 48-volt power shelf, how should we think about the potential for that product? How many other competitors can make a similar product?

I would say we're one of the first out there with a 48-volt power shelf for this level of efficiency and power density. I think it more than meets the needs of the leading customers in the hyperscale market. We think we're well positioned with this platform to move forward and do further customization to meet our customers' needs.

Okay. And the last one for me, just on the CapEx plans for this year, any large projects worth flagging?

We always have a variety of things. Steve talked about some facility improvements, and potentially some capacity increases around equipment. Our CapEx needs are pretty low, and I expect we'll stay within our model of 2% to 3%. We don't see anything that would drive us significantly beyond that, 2% to 3% of revenue.

And our next question comes from the line of Steve Barger with KeyBanc Capital Markets.

I know industrial and medical has been a focus for share gains and growth. As you've gone through this team reorganization, have you seen those order rates accelerate? Or can you talk about book-to-bill rates for I&M versus the other segments or versus prior year, however you want to frame it?

Yes, we're not ready to get into that level of detail yet, Steve. What I can say is we have significantly increased the number of engineers designing products for the industrial medical market. We are seeing increased output already, and that's going to continue to increase in the coming quarters. The second thing we've done is really refocus a significant part of our sales and FAE force on industrial and medical applications. The pipeline is getting bigger, and we're definitely encouraged because this is really right in our wheelhouse. These are long life cycle, typically sole source type products, and that's what we're good at.

I was just going to say, just commenting, Steve, this was a record quarter for industrial and medical from revenue, as Steve commented about in his prepared remarks. We also noted that backlog increased again for these products. Clearly, there's a lot of demand. We're winning new positions, and as we get parts, there's a lot of room for revenue growth here.

Yes, that was my follow-up. For the industrial side, are you targeting niche manufacturing of really specialty products and on the medical side, is it really medical device manufacturers? Or what's kind of the approach that you're taking?

Yes. Steve, I would say most of the opportunities here are going to be small and medium-sized opportunities. It's a lot of singles and doubles in the industrial and medical market, but the opportunities last for a long time. We're able to build upon them, but each of these customers. That's really kind of the business it is, and it tends to average up our corporate gross margin. So that's why we've put so much horsepower behind that effort.

And we have reached the end of our question-and-answer session. Therefore, I will now turn the call over to Steve Kelley for closing remarks.

Okay. Thank you. A few closing thoughts. First, the demand for our products is very strong. Second, as supply conditions improve, we expect to drive improved performance. Finally, we are focused on accelerating the execution of our strategy to bring best-in-class precision power solutions to customers in our target markets. Thank you for joining the call today.

This concludes today's conference, and you may disconnect your lines at this time. Thank you for your participation.